| Food aid basket missing critical ingredients |
| |
"Unfortunately donors continue to apply a 'one size fits all' approach to nutritional aid," said Dr. Shepherd, nutritional advisor for MSF. "The wrong food aid can mean children will still get malnourished and fall ill or die unnecessarily."
 Find out more...
|
| MSF and TB experts call for new approach to test TB drugs - Donors and developers need to respond to the strategy |
| |
More PLOS articles on TB
A new approach to over-coming the bottlenecks in the search for TB drugs ..here
Massive expansion of clinical trials capacity is urgently needed ..here
The time is right for trials of multidrug-resistant TB therapy ..here
|
"This is quite simply the best hope we have of getting improved medicines to patients with multidrug-resistant TB faster," said Dr. Eric Goemaere, MSF Head of Mission,in South Africa. "We cannot afford to wait."
Find out more...
|
| TB: Fighting a losing battle? |
| |
"MDR-TB, and now XDR-TB are the tip of an iceberg of failing strategies to curb TB. We desperately need new tools and we need them now - we cannot just sit and wait," said Dr. Tido von Schoen-Angerer, Director of MSF's Campaign for Access to Essential Medicines. "There is no quick ready-made solution, but that is not an excuse not to act."
Find out more...
|
| MSF denounces Abbott's move to withhold medicines from people in Thailand |
| |
Melting drugs make nonsense of treatment
"The drug was registered in the US in October 2005, but still cannot be used in Thailand and many other countries where it is desperately needed. Refusing to sell the drug here is a major betrayal to patients."
- Dr. David Wilson, of MSF in Thailand.
|
"Thailand's move to issue compulsory licenses is an important way to help bring prices down and increase availability of medicines," said Ellen 't Hoen, Policy Director at MSF's Campaign for Access to Essential Medicines. "In light of this, Abbott's move is appalling."
MSF is calling on WHO, UNAIDS, governments, and other international bodies to denounce Abbott's move.
Find out more...
|
| MSF welcomes the introduction of a new open-source, user-friendly drug combination against malaria |
| |
The treatment is the result of research by the non-profit Drugs for Neglected Diseases initiative (DNDi) in cooperation with Sanofi-Aventis and demonstrates how research and development can take place without patenting for availability in the public domain.
"Combining two drugs in one tablet is a significant improvement because it will make malaria treatment much easier for patients", says Dr. Michel Queré, medical coordinator for MSF in Chad, where medical teams treated nearly 80,000 patients for malaria in 2006. "Children, for example, will only have to take one - instead of four - tablets a day for a three-day treatment. This will increase adherence and reduce the risk of drug-resistance".
Find out more...
|
|
|
